期刊文献+

腹膜透析患者腹膜超滤衰竭的新靶点:腹膜血管的生成 被引量:2

A New Target of Peritoneal Ultrafiltration Failure in Peritoneal Dialysis Patients:Peritoneal Angiogenesis
下载PDF
导出
摘要 目的:综述腹膜透析患者腹膜超滤衰竭的主要原因。方法:通过查阅文献,从目前对腹膜超滤衰竭的发生,腹膜结构和功能的改变,综述腹膜血管生成特征的研究进展。结果:多种原因可促进腹膜血管内皮生长因子(VEGF)表达、促进腹膜新生血管的增生,从而增加腹膜转运的有效滤过面积,减少超滤量,腹膜新生血管的生成是患者腹膜超滤衰竭的主要原因。结论:引起腹膜超滤衰竭发生的诸多原因及机制中,腹膜组织新生血管形成占主导地位,是腹膜超滤衰竭病因学的研究热点,多种方法可能可以干预新生血管的形成。 Objective: To analyze the major causes and tactics of ultrafiltration failure in long peritoneal dialysis patients. Methods: Through a large number of documents, we reviewed the characteristics of peritoneal angiogenesis research progress from the current points of incidence of peritoneal ultrafihration failure, and the change of peritoneal structure and function. Results: Various causes can stimulate the expression of VEGF in peritoneal membrane tissue, and promote the proliferation of new vascular, which result in increased effective peritoneal surface area of peritoneal membrane and reducd ultrafihration. Peritoneal angiogenesis was the main reason of peritoneal ultrafiltration failure. Conclusion: Peritoneal angiogenesis was the major reason of peritoneal ultrafiltration failure, which was also the research focus. There were a variety of methods to interfere the formation of new blood vessels.
出处 《大理学院学报(综合版)》 CAS 2011年第6期64-67,共4页 Journal of Dali University
关键词 腹膜透析 超滤衰竭 血管内皮生长因子 peritoneal dialysis ultrafihration failure VEGF
  • 相关文献

参考文献15

  • 1Mujais S, Nolph K, Gokal R, et al. Evaluation and management of ultrafihration problems in peritoneal dialysis. International Society for Pertioneal Dialysis Ad Hoc Committee on Ultrafitration Management in Peritoneal Dialysis [J]. Petit Dial Int,2000,20(4): 15-21.
  • 2郑智华,马祖等,郝元涛,黄锋先,余学清.持续性非卧床腹膜透析患者生存质量影响因素的研究[J].中华肾脏病杂志,2005,21(5):290-294. 被引量:51
  • 3Yuan J Z, Fang W, Ni Z H, et al. Peritnoeal Morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tic-2 [J]. Pediatr Nephrol, 2009,24 ( 3 ) : 163- 170.
  • 4Smit W,Sehoulen N,van den Berg N,et al.Analysis of he prevalence and causes of uhrafihration failure during long- term peritoneal dialysis:a corss -sectional study [J].Perit Dial lnt, 2004,24( 6 ) : 506-508.
  • 5林爱武,钱家麒.如何解决腹膜透析患者的容量超荷问题[J].肾脏病与透析肾移植杂志,2006,15(1):82-84. 被引量:8
  • 6Williams J D, Craig K J, Topley N, et al. Peritoneal Biopsy Study Group:Morphologic changes in the peritoneal membrane of patients with renal disease[J]. J Am Soc Nephrol, 2002, 13(2):470-479.
  • 7Rippe B,Venturoli D.Simulations of osmotic uhrafiltration failure in CAPD using a serial three pore membrane/fiber matrix model [J].Am J Physiol Renal Physiol, 2007,292(2): 1035-1043.
  • 8Liu T,Owen W,Yu YM,et al.Arginine,eitmlline,and nitric oxide metabolisin in end-stage renal disease patients.J Clin Invest,2000, 105(9): 1217-1225.
  • 9Duyndma MC,Hilhorst MC,Schluper HM,et al.Vascular endothelial growth factor-165 over expression stimulates angiogenesis and induces cyst formation and maerophage infiltration in human ovarian eaneer xenografls[J].Am J Pathol, 2002,160( 5 ) : 537-554.
  • 10杨琼琼,叶任高,阳晓,彭文兴,余学清.含糖透析液对慢性腹膜透析大鼠腹膜功能及间皮细胞形态的影响[J].中国病理生理杂志,2004,20(8):1377-1380. 被引量:5

二级参考文献59

共引文献73

同被引文献18

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部